ShedRx Cost: Understanding Compounded GLP-1 Pricing and Clinical Value

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

ShedRx cost ranges from approximately $100 to $300+ monthly, depending on formulation strength and subscription tier. Compounded GLP-1 medications—including semaglutide, tirzepatide, and dual-compound protocols—carry distinct pricing because raw material costs, sterility standards, and pharmacy licensing differ from mass-manufactured alternatives.

Cost alone does not reflect clinical value. A lower monthly price may mask inadequate dosing or a medication formulation that does not match your metabolic profile. Understanding what drives pricing—and how genetic factors related to GLP-1 receptor sensitivity may influence medication selection—enables more informed conversations with your provider about value.

Why Compounded GLP-1 Pricing Varies Across Providers

Compounded medications are prepared by licensed 503A pharmacies under precise sterility protocols and federal oversight. Raw material sourcing, quality assurance testing, and pharmacist compounding labor contribute directly to cost. Bioavailability optimization for oral versus injectable formulations also affects final pricing.

Subscription models offer volume discounts but require commitment. Single-month orders cost more per unit than three- or six-month supplies. Geographic location, pharmacy licensing tier, and local regulatory compliance may introduce modest price variation even within the compounded GLP-1 market.

Compounded GLP-1 Formulations and Their Cost Structure

Different GLP-1 formulations target distinct metabolic pathways and carry different production costs. Semaglutide, tirzepatide, and dual-compound protocols (combining GLP-1 and GIP receptor agonists) each require unique manufacturing processes and raw material investments. Choosing the right formulation for your metabolism can maximize the clinical return on your investment.

Formulation Type	Typical Monthly Cost Range	Key Clinical Distinction
Compounded Semaglutide Injection	$149	Single GLP-1 agonist; foundational appetite and glucose regulation.
Oral Compounded Semaglutide	$209+	Oral bioavailability enhanced; no injection required; may cost more for formulation complexity.
Compounded Tirzepatide Injection	$249	Dual GLP-1 and GIP agonist; broader metabolic impact; typically higher cost reflects dual-pathway activity.
Oral Compounded Tirzepatide	$279	Oral tirzepatide with enhanced absorption technology; highest cost reflects formulation innovation.
Microdose GLP-1 Protocol	$129	Lower-dose entry point; lower cost; used for tolerance building or mild metabolic support.
GLP-Squared Dual Compound	$249	Proprietary dual-compound design; cost reflects bespoke formulation and dual-mechanism benefit.

How Genetic Predisposition May Influence Medication Cost-Effectiveness

Not all GLP-1 medications produce equivalent results in every patient. Genetic variants in the GLP1R gene (rs6923761) and GIPR gene (rs1800437) affect receptor sensitivity and may influence how quickly you respond to therapy. A patient with high GLP-1 receptor sensitivity may achieve results at lower doses or with less frequent dosing adjustments, reducing long-term cost.

Conversely, variants associated with lower baseline receptor sensitivity may require higher doses or progression to dual-mechanism compounds like tirzepatide. Understanding your genetic predisposition in peptide pathways helps your provider select the most clinically appropriate—and cost-effective—starting point rather than trial-and-error dosing that prolongs expenses.

Evaluating Cost Within Clinical Safety and Provider Oversight Framework

Lowest-cost options may come from providers offering minimal medical supervision or from non-licensed compounding sources. Licensed 503A compounding pharmacies (used exclusively by PlexusDx) operate under rigorous federal oversight, including sterility testing, identity verification, and compounding accuracy audits. This regulatory compliance carries legitimate cost but protects your safety.

Your provider should evaluate whether dosing adjustments, biomarker monitoring, or medication switches align with your clinical response rather than budget alone. A seemingly expensive quarterly assessment with genetic testing may prevent months of wasted spending on an unsuitable medication. Frame cost decisions within total clinical value, not isolated monthly price.

How PlexusDx Supports a More Personalized Approach

PlexusDx Precision Peptide Genetic Test reveals predispositions in GLP-1 and GIP receptor pathways (GLP1R rs6923761, GIPR rs1800437), FTO gene variants (rs9939609), and melanocortin-4 receptor sensitivity (MC4R rs17782313). These genetic insights may help provide context for why certain compounded formulations and dosing strategies align better with your metabolic profile—and how medication selection affects long-term cost-effectiveness.

The genetic test does not predict your exact medication response or guarantee outcomes. Instead, it reveals predispositions in peptide genetic pathways that should be interpreted with your qualified healthcare provider to support a more personalized conversation about which formulation and dosing approach may optimize both clinical benefit and cost efficiency for your unique biology.

Understanding your genetic context alongside current cost analysis enables more strategic medication selection. Rather than choosing the cheapest option or the highest-cost therapy, you and your provider can align compounded GLP-1 formulation, dosing, and monitoring frequency with your genetic predispositions—potentially reducing wasted spending on mismatched medications and improving clinical durability.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is included in ShedRx monthly subscription costs?

ShedRx subscription typically includes the compounded medication, online provider consultations, and access to a patient portal. Additional costs may apply for lab work, genetic testing, or specialty formulations. Verify exact inclusions with your selected provider plan.

Are compounded GLP-1 medications FDA-approved?

Compounded medications are not FDA-approved as finished products; they are prepared under 503A pharmacy licensure and federal oversight. The active ingredients (semaglutide, tirzepatide) are FDA-approved drugs, but compounded preparations are legally permissible for patient-specific use under physician supervision.

How does PlexusDx compounded GLP-1 pricing compare to ShedRx?

PlexusDx compounded semaglutide starts at $149/mo, tirzepatide at $249/mo, and microdose protocols at $129/month—all from licensed 503A pharmacies. Exact pricing depends on formulation, dosage, and subscription duration. Request a quote for direct comparison with other providers.

Can genetic testing help justify the cost of a higher-dose medication?

Genetic predispositions in GLP-1 receptor and metabolic pathways may inform dosing strategy and medication choice. PlexusDx Precision Peptide Genetic Test costs $99 as an add-on or $298 standalone and may help your provider select the most appropriate formulation—potentially reducing costly trial-and-error adjustments over time.

What should I look for when comparing GLP-1 cost across providers?

Compare licensed pharmacy status (503A only; avoid 503B), provider oversight quality, monitoring frequency, inclusion of biomarker or genetic assessment, and total cost over 3–6 months rather than single-month pricing. Lowest cost rarely reflects safest or most effective long-term care.